Sivik Global Healthcare LLC boosted its position in UnitedHealth Group Inc (NYSE:UNH) by 21.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 25,000 shares of the healthcare conglomerate’s stock after acquiring an additional 4,427 shares during the quarter. UnitedHealth Group accounts for 2.4% of Sivik Global Healthcare LLC’s holdings, making the stock its 16th largest holding. Sivik Global Healthcare LLC’s holdings in UnitedHealth Group were worth $6,651,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. Dimensional Fund Advisors LP grew its stake in shares of UnitedHealth Group by 0.5% during the third quarter. Dimensional Fund Advisors LP now owns 3,157,170 shares of the healthcare conglomerate’s stock worth $839,896,000 after buying an additional 17,040 shares during the last quarter. Meiji Yasuda Life Insurance Co grew its stake in shares of UnitedHealth Group by 1.6% during the third quarter. Meiji Yasuda Life Insurance Co now owns 32,381 shares of the healthcare conglomerate’s stock worth $8,615,000 after buying an additional 510 shares during the last quarter. Virtu Financial LLC grew its stake in shares of UnitedHealth Group by 16.0% during the third quarter. Virtu Financial LLC now owns 11,442 shares of the healthcare conglomerate’s stock worth $3,044,000 after buying an additional 1,580 shares during the last quarter. Panagora Asset Management Inc. grew its stake in shares of UnitedHealth Group by 0.7% during the third quarter. Panagora Asset Management Inc. now owns 1,510,829 shares of the healthcare conglomerate’s stock worth $401,941,000 after buying an additional 10,979 shares during the last quarter. Finally, FDx Advisors Inc. grew its stake in shares of UnitedHealth Group by 9.6% during the third quarter. FDx Advisors Inc. now owns 42,165 shares of the healthcare conglomerate’s stock worth $11,218,000 after buying an additional 3,697 shares during the last quarter. 85.57% of the stock is currently owned by institutional investors and hedge funds.

A number of research firms have weighed in on UNH. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, November 21st. Cantor Fitzgerald reissued a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, November 21st. BMO Capital Markets set a $310.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday, November 27th. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $295.00 to $300.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 28th. Finally, Piper Jaffray Companies boosted their price objective on shares of UnitedHealth Group to $312.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 28th. Two equities research analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $292.48.

UNH stock opened at $269.18 on Friday. The firm has a market capitalization of $266.34 billion, a P/E ratio of 26.73, a PEG ratio of 1.59 and a beta of 0.76. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 0.61. UnitedHealth Group Inc has a 12-month low of $208.48 and a 12-month high of $287.94.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.30 by $0.11. The business had revenue of $56.56 billion for the quarter, compared to analyst estimates of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. UnitedHealth Group’s revenue for the quarter was up 12.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.66 earnings per share. Equities analysts anticipate that UnitedHealth Group Inc will post 12.82 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be issued a $0.90 dividend. The ex-dividend date of this dividend is Friday, November 30th. This represents a $3.60 annualized dividend and a yield of 1.34%. UnitedHealth Group’s payout ratio is 35.75%.

In related news, Director Richard T. Burke sold 20,000 shares of the business’s stock in a transaction on Wednesday, September 12th. The shares were sold at an average price of $263.41, for a total value of $5,268,200.00. Following the transaction, the director now owns 1,720,112 shares in the company, valued at $453,094,701.92. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Richard T. Burke sold 6,090 shares of the business’s stock in a transaction on Wednesday, November 28th. The shares were sold at an average price of $281.72, for a total transaction of $1,715,674.80. Following the completion of the transaction, the director now owns 1,711,584 shares in the company, valued at approximately $482,187,444.48. The disclosure for this sale can be found here. In the last 90 days, insiders sold 34,395 shares of company stock worth $9,186,302. 0.87% of the stock is owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This story was first posted by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The correct version of this story can be accessed at https://www.watchlistnews.com/unitedhealth-group-inc-unh-position-lifted-by-sivik-global-healthcare-llc/2671030.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: Trading Penny Stocks

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.